Bionexum Ventures is dedicated to the identification, evaluation, analysis and investment recommendation of biopharmaceutical projects and assets to continue the pharmaceutical development . Additionally, Bionexum Ventures may participate in financing of early stage biotechnology companies with outstanding technologies. Bionexum Ventures is run by Dr. Juan José Pérez Villar, founder and managing director of Bionexum Ventures, holds a degree in Biochemistry and a Ph.D. in Immunology and Inflammation by the Autonoma University of Madrid (UAM). Dr. Pérez Villar has developed an extensive international career in the pharmaceutical industry designing operations of out / in-licensing for pharmaceutical products, strategic analysis and launching of biotech companies. Currently, he is CEO of the imumno oncology company Leadartis (www.leadartis.com); previously, he was business development director of Biolty (Madrid, Spain), a consulting firm specialized in the biopharmaceutical sector, Manager of Business Development and associate Director in the department of oncology at the biopharmaceutical company Agensys / Astellas Inc. (Santa Monica, CA, USA), and Principal Investigator, department of oncology at the multinational pharmaceutical company Bristol-Myers Squibb Co. (Princeton, NJ, USA).